Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

You searched for +publisher:"McMaster University" +contributor:("McInnes, Natalia"). One record found.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


McMaster University

1. Sultan, Farah. EFFECTS OF PROBIOTIC SUPPLEMENTATION ON INDUCING REMISSION TO DRUG-FREE NORMOGLYCEMIA IN ADULTS WITH PREDIABETES – STUDY DESIGN.

Degree: MSc, 2017, McMaster University

Study design of a randomized-controlled trial investigating the effects of probiotic supplementation on induction of prediabetes remission to normoglycemia in adults with prediabetes.

BACKGROUND: Patients with prediabetes are at a high risk of developing type 2 diabetes (T2D) and the current strategies to prevent the progression of prediabetes to T2D are difficult to implement at the population level. Recently, the role of gut microbiota has emerged as a possible link to metabolic disease. The modulation of the gut microbiota in individuals with prediabetes through probiotic supplementation may improve metabolic dysfunction and induce remission of prediabetes to normoglycemia. OBJECTIVES: The primary objective of this trial is to determine the effect of 900 billion CFU/day of VSL#3®, a multi-strain probiotic supplement for 20 weeks, on induction of drug-free remission to normoglycemia (HbA1c<6.0%) in adults with prediabetes compared to placebo 20 weeks post-randomization. METHODS: In a randomized, triple-blind, controlled multi-centre trial, 568 adults with prediabetes will undergo a 2-week run-in after which they will be randomly allocated to 20 weeks of either 900 billion CFUs of VSL#3® per day or placebo. Prediabetes remission will be measured using HbA1C at week 20 and 32. Change in insulin resistance (HOMA-IR), beta-cell function (HOMA-B), weight, BMI, waist circumference and fecal relative abundance of bacteria will be measured from baseline at week 20 and 32. Exploratory regression analyses will involve a multiple logistic regression model to assess whether the change in relative abundance of the Rosburia genus from baseline at week 20 is an independent predictor of drug-free prediabetes remission at week 20. DISCUSSION: Individuals with prediabetes are at high risk of developing T2D and the induction of prediabetes remission would be important to patients and clinicians. The role of microbiota in metabolic processes presents the potential for therapeutic applications of probiotics. If successful, probiotics would offer a therapeutic option for reversing prediabetes to normoglycemia that is simple, cheap and easy to incorporate into standard clinical care.

Thesis

Master of Science (MSc)

BACKGROUND: Patients with prediabetes are at a high risk of developing type 2 diabetes (T2D) and the current strategies to prevent the progression of prediabetes to T2D are difficult to apply at the population level. Recently, the role of gut bacteria has emerged as a possible link to metabolic disease. Changing the gut microbiota in people with prediabetes through probiotic supplements may improve metabolic function and result in remission of prediabetes to normal glucose control. OBJECTIVES: The primary objective of this study is to determine the effect of VSL#3®, a probiotic supplement, for 20 weeks, on induction of drug-free remission to normal glucose control in adults with prediabetes compared to placebo, 20 weeks after randomization. METHODS: In a randomized, triple-blind, controlled multi-centre…

Advisors/Committee Members: McInnes, Natalia, Clinical Epidemiology/Clinical Epidemiology & Biostatistics.

Subjects/Keywords: study design; protocol; randomized controlled trial; diabetes; probiotics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sultan, F. (2017). EFFECTS OF PROBIOTIC SUPPLEMENTATION ON INDUCING REMISSION TO DRUG-FREE NORMOGLYCEMIA IN ADULTS WITH PREDIABETES – STUDY DESIGN. (Masters Thesis). McMaster University. Retrieved from http://hdl.handle.net/11375/22258

Chicago Manual of Style (16th Edition):

Sultan, Farah. “EFFECTS OF PROBIOTIC SUPPLEMENTATION ON INDUCING REMISSION TO DRUG-FREE NORMOGLYCEMIA IN ADULTS WITH PREDIABETES – STUDY DESIGN.” 2017. Masters Thesis, McMaster University. Accessed November 22, 2019. http://hdl.handle.net/11375/22258.

MLA Handbook (7th Edition):

Sultan, Farah. “EFFECTS OF PROBIOTIC SUPPLEMENTATION ON INDUCING REMISSION TO DRUG-FREE NORMOGLYCEMIA IN ADULTS WITH PREDIABETES – STUDY DESIGN.” 2017. Web. 22 Nov 2019.

Vancouver:

Sultan F. EFFECTS OF PROBIOTIC SUPPLEMENTATION ON INDUCING REMISSION TO DRUG-FREE NORMOGLYCEMIA IN ADULTS WITH PREDIABETES – STUDY DESIGN. [Internet] [Masters thesis]. McMaster University; 2017. [cited 2019 Nov 22]. Available from: http://hdl.handle.net/11375/22258.

Council of Science Editors:

Sultan F. EFFECTS OF PROBIOTIC SUPPLEMENTATION ON INDUCING REMISSION TO DRUG-FREE NORMOGLYCEMIA IN ADULTS WITH PREDIABETES – STUDY DESIGN. [Masters Thesis]. McMaster University; 2017. Available from: http://hdl.handle.net/11375/22258

.